Beam Therapeutics (BEAM) Capital Leases (2019 - 2023)

Beam Therapeutics (BEAM) has 5 years of Capital Leases data on file, last reported at $304000.0 in Q3 2023.

• On a quarterly basis, Capital Leases fell 78.1% year-over-year to $304000.0 in Q3 2023; TTM through Sep 2023 was $304000.0, a 78.1% decrease from a year earlier, with the FY2022 full-year figure at $1.2 million, down 61.62% from the prior year.
• Capital Leases for Q3 2023 stood at $304000.0, down from $875000.0 in the prior quarter.
• Over the last five years, Capital Leases for BEAM reached as high as $5.3 million in Q1 2020 and fell as low as $304000.0 in Q3 2023.
• Historically, Capital Leases has averaged $3.0 million across 5 years, with a median of $3.3 million in 2021.
• Across the five-year window, Capital Leases rose 20.02% in 2020 and slumped 78.1% in 2023, its largest moves.
• Year by year, Capital Leases stood at $4.4 million in 2019, then gained by 20.02% to $5.3 million in 2020, then plunged by 43.2% to $3.0 million in 2021, then tumbled by 61.62% to $1.2 million in 2022, then sank by 73.66% to $304000.0 in 2023.
• Per Business Quant data, the three most recent Capital Leases figures were $304000.0 in Q3 2023, $875000.0 in Q2 2023, and $983000.0 in Q1 2023.